Author: Lu, Patrick Y.; Xie, Frank Y.; Woodle, Martin C.
Title: Modulation of angiogenesis with siRNA inhibitors for novel therapeutics Cord-id: udcw1mx5 Document date: 2005_2_4
ID: udcw1mx5
Snippet: Cancer and many other serious diseases are characterized by the uncontrolled growth of new blood vessels. Recently, RNA interference (RNAi) has reinvigorated the therapeutic prospects for inhibiting gene expression and promises many advantages over binding inhibitors, including high specificity, which is essential for targeted therapeutics. This article describes the latest developments using small-interfering RNA (siRNA) inhibitors to downregulate various angiogenic and tumor-associated factors
Document: Cancer and many other serious diseases are characterized by the uncontrolled growth of new blood vessels. Recently, RNA interference (RNAi) has reinvigorated the therapeutic prospects for inhibiting gene expression and promises many advantages over binding inhibitors, including high specificity, which is essential for targeted therapeutics. This article describes the latest developments using small-interfering RNA (siRNA) inhibitors to downregulate various angiogenic and tumor-associated factors, both in cell-culture assays and in animal disease models. The majority of research efforts are currently focused on understanding gene function, as well as proof-of-concept for siRNA-mediated anti-angiogenesis. The prospects for siRNA therapeutics, both advantages and looming hurdles, are evaluated.
Search related documents:
Co phrase search for related documents- absence presence and acid inhibitor: 1, 2
- absence presence and action mechanism: 1, 2, 3, 4, 5, 6
- absence presence and activation migration: 1, 2
- absence presence and adhesion mmps: 1
- absence presence and adhesion molecule: 1, 2, 3, 4
- absence presence and local delivery: 1
- absence presence and low similar: 1, 2
Co phrase search for related documents, hyperlinks ordered by date